Abstract Oxidative damage due to low levels of glutathione (GSH) is one of the main causes of cataract formation. It has been reported that 2-oxothiazolidine-4-carboxylic acid (OTZ), a cysteine prodrug, can increase the cellular level of GSH. Currently, there is no analytical method to separate and quantify OTZ from aqueous humour samples for cataract research. The present study aims to develop and validate a hydrophilic interaction liquid chromatography (HILIC) method for the quantification of OTZ in simulated aqueous humour (SAH). The developed method was validated according to FDA guidelines. Accuracy, precision, selectivity, sensitivity, linearity, lower limit of quantification (LLOQ), lower limit of detection (LLOD) and stability were the parameters assessed in the method validation. The developed method was found to be accurate and precise with LLOQ and LLOD of 200 and 100 ng/mL, respectively; method selectivity was confirmed by the absence of any matrix interference with the analyte peak. The constructed calibration curve was linear in the range of 0.2-10 μg/mL, with a regression coefficient of 0.999. In addition, the OTZ was found to be stable in SAH after three freeze/thaw cycles. Chitosan nanoparticles loaded with OTZ were formulated by the ionic gelation method. The nanoparticles were found to be uniform in shape and well dispersed with average size of 153 nm. The in vitro release of OTZ from the nanoparticles was quantified using the developed analytical method over 96 h. Permeation of OTZ through excised bovine cornea was measured using HILIC. The lag time and the flux were 0.2 h and 3.05 μg/cm 2 h, respectively.
Introduction
Cataract, a major source of sight impairment, is estimated to affect more than 18 million people worldwide and is thought to be caused by protein modifications that attenuate light transmission by scattering and/or absorption, thereby detrimentally affecting the transparency of the eye lens. While glutathione (GSH) is a major antioxidant in the lens, cysteine has also been found to play a key antioxidant role in the lens nucleus. L-2-Oxothiazolidine-4-carboxylic acid (OTZ) is a cysteine prodrug that can increase the cellular level of GSH [1] . OTZ, a secondary precursor for GSH, is enzymatically metabolised to cysteine by the action of 5-oxoprolinase and, thus, increases the overall level of GSH [1] . Therefore, a simple topical solution of OTZ might enhance the intracellular level of GSH. Nevertheless, after instillation of a conventional eye drop, extensive precorneal loss caused by nasolacrimal drainage and high tear fluid turnover leads to a relatively short precorneal contact time, hence reduced ocular bioavailability [2] .
In the last few decades, nano-systems have attracted attention in drug delivery research. Chitosan is used in the preparation of nanoparticles due to its appealing properties. The positive surface charge of chitosan renders it attractive for ocular drug delivery, as chitosan nanoparticles are likely to interact with the negatively charged surface of the eye. It is likely to increase the residence time of the drug and prolong precorneal retention time, thereby enhancing ocular drug bioavailability [2] .
The present study reports on the development and validation of a new highly sensitive HILIC method for separation and quantification of the released/permeated OTZ in simulated aqueous humour (SAH). The method was used to quantify OTZ release from chitosan nanoparticles and permeation through excised bovine cornea.
Experimental

Materials
OTZ was obtained from MP Biomedicals (CA, USA). Ammonium acetate, HPLC grade acetonitrile, sodium hydroxide, sodium sulphate, calcium chloride and glucose were purchased from Fisher Scientific (Loughborough, UK). All other reagents were purchased from Sigma-Aldrich (Dorset, UK). Analytical grade chemicals were used as received unless mentioned otherwise.
Stock solutions and standards
Simulated aqueous humour (SAH) was prepared following an existing procedure [3] with some modification. A master stock solution of OTZ was freshly prepared by dissolving OTZ (10 mg) in SAH (10 mL) in a volumetric flask. Different concentrations (0.2, 0.5, 1, 2, 3, 5 and 10 μg/mL) were prepared from the stock solution; these concentrations were used to construct the calibration curve for validation. In addition, quality control solutions were prepared by diluting the master stock solution with SAH. Samples were stored at 4°C until further use.
Chromatographic conditions
The method was developed and validated using a Shimadzu LC-2010HT (Kyoto, Japan) HILIC system which is comprised of a serial dual plunger, micro volume pump, automatic degasser, thermostatic autosampler and a column oven. The system uses a deuterium lamp UV detector set at 265 nm. Separation and quantification were achieved using a HILIC column (Kinetex 100×4.6 mm) with a pre-column ultra-cartridge security guard (Phenomenex, California, USA); the column was maintained at 30°C. The mobile phase consisted of acetonitrile (phase A) and 10 mM ammonium acetate (phase B). Optimum separation was obtained when the mobile phases were run in a linear gradient mode starting with 95 % acetonitrile and ending with 95 % ammonium acetate (at a flow rate of 1.5 mL/min) with a run time of 15 min, followed by additional 2 min for column conditioning.
Method validation
The developed method was validated according to FDA guidelines. Accuracy, precision, linearity, lower limit of detection (LLOD), lower limit of quantification (LLOQ), selectivity, sensitivity, and stability were the fundamental parameters for validation of the developed method. The calibration curve of area under the curve versus concentration was constructed from the seven concentrations that were prepared from the stock solution (as described above). Three different quality control samples-quality control low (QCL), quality control medium (QCM) and quality control high (QCH)-were prepared to determine the accuracy and intra-and inter-day precisions; these samples were equally distributed over the linear range of the calibration curve. Six replicas of each quality control concentration were measured. The accuracy of the method was calculated by comparing the measured mean of the six replicas of each concentration with the respective nominal values. The calculated mean value for four of the six quality control sample replicas should not deviate by more than ±15 %, with the exception of the LLOQ for which the mean value should be within ±20 %. For the intra-day precision experiment, six replicas of the same concentration were measured on the same day, while the inter-day precision was determined by measuring six replicas of the same concentration on three consecutive days. The coefficient of variation (CV) was used to give an indication of the precision of the developed method. A CV value of ±15 % was considered acceptable for all quality control samples apart from LLOQ whereCV value of ±20 were deemed acceptable. A blank sample was introduced between the analyses; the absence of any interference from the matrix peaks with the analyte peaks was deemed an acceptable indication of method selectivity. Finally, linear regression analysis was used to test for method linearity. To assess the stability of the method, a SAH spiked with OTZ was stored at −20°C and three freeze/thaw cycles were performed.
OTZ-loaded chitosan nanoparticles
Chitosan nanoparticles were formulated by ionic gelation [4] . Briefly, OTZ (0.6 mg/mL) was added to chitosan solution (5 mL; 1.75 mg/mL); the solution was stirred for 1 h. TPP solution (2 mL; 1.5 mg/mL) was added drop wise to this solution. This resulted in a particulate dispersion which was placed in an ice bath and sonicated for 30 s. This dispersion was centrifuged at 40,000g for 30 min. The nanoparticles obtained were re-dispersed in water. Particle size and ζ-potential of the prepared particles were measured at 20°C using a Malvern Mastersizer 3000HSA, UK. Scanning electron microscopy (SEM) (Zeiss EVO50, Germany) and atomic force microscopy (AFM) (MultiMode/NanoScope IV scanning probe microscope, Santa Barbara, Bruker, USA) were used to characterise the morphology of the prepared particles. AFM experiments were performed, as described elsewhere [5] . The images were then processed and height profiles extracted using NanoScope Analysis software (V 1.4, Bruker, CA, USA). SEM samples were prepared as follows: One drop of the nanoparticle suspension was placed on a slide cover and left to dry overnight. The slide cover was then attached to an aluminium stud using double-sided adhesive conductive carbon tape. The sample was coated with a layer of gold/ palladium using sputter coating and then analysed under high vacuum at a voltage of 20 kV.
In vitro release study of OTZ A dialysis membrane (10,000 Da MWCO) was soaked overnight in SAH. A Franz cell diffusion apparatus (FDC-6, Logan Instrument Corp., Somerset, NJ, USA) was used. The receptor compartment (orifice diameter 15 mm) was filled with SAH (12 mL), and a dispersion of OTZ-loaded chitosan nanoparticles (2 mL) was placed in the donor compartment. The two compartments were separated by the dialysis membrane. The temperature of the cell was maintained at 35±0.5°C. At hourly intervals, an aliquot (400 μL) was withdrawn from the receptor compartment for analysis; this volume was replaced with fresh SAH. The OTZ released from the nanoparticles was quantified by the developed HILIC method.
Ex vivo corneal permeation of OTZ Corneal permeation of OTZ was investigated using the Franz cell diffusion apparatus. The two compartments were separated by a freshly excised bovine cornea (endothelium facing the receptor compartment). The temperature of the cell was maintained at 35±0.5°C. A sample (400 μL) was withdrawn from the receptor compartment at set time intervals (every 1 h) and replaced with fresh SAH. The samples were analysed for permeated OTZ by HILIC. The apparent permeability coefficient (P app ) was calculated from the amount of OTZ permeated versus time plot using:
where ΔQ=Δt is the mass (μg) permeated at different time (h) points (μg/h) of OTZ through the excised bovine corneas, C 0 is the initial concentration (μg/mL) of OTZ and A is the area of the Franz cell orifice (cm 2 ). Lag time was obtained by dividing the value of the intercept over the slope; the latter represents the value of the P app of OTZ.
Results and discussion
Method development and validation
Separation and quantification of OTZ, a small hydrophilic molecule, by HPLC have been reported previously [6] . The reported method had some shortcomings; separation of OTZ by conventional HPLC is challenging because of the highly hydrophilic nature of the OTZ rendering it too polar for conventional HPLC column separation [7] . HILIC is an alternative HPLC mode for separation of polar compounds using the same mobile phases used in normal phase liquid chromatography; it combines the appropriate features of both normal and reverse phase liquid chromatography [7] . HILIC utilises the same stationary phase of normal phase liquid chromatography while the mobile phase is similar to that used in reverse phase liquid chromatography. Different combinations of the mobiles phases were used during the method development; a small amount of water with a water miscible organic solvent is considered to be a good combination of mobile phases. The HILIC column relies on the presence of a bilayer of the two mobile phases [7] ; therefore, a limit of 95 % of either mobile phase was maintained. In contrast to reverse-phase liquid chromatography, the gradient run for a HILIC column begins with an excess of organic phase over the aqueous phase to improve column retention [8] . Therefore, a gradient mode was adopted starting with 75 % of acetonitrile and ending with 75 % of ammonium acetate; this resulted in good separation but with a long retention time. By increasing the acetonitrile level to 95 % and ending with 95 % of the aqueous phase, the optimum separation with the shortest retention time was achieved. The running time for the method was 15 min, followed by 2 min column reconditioning with 95 % acetonitrile.
The developed method showed good linearity between 0.2 and 10 μg/mL (quantification range) with a regression coefficient of 0.999. The LLOD for OTZ in SAH was 100 ng/mL with signal/noise (S/N) ratio of 6.5, while the LLOQ was found to be 200 ng/mL with 14.42 as S/N ratio. The accuracy and inter-and intra-day precision were found to be within the limits set by the FDA guidelines (Table 1) . No interference between the analyte and blank (SAH) peaks was identified which confirmed the method selectivity (Fig. 1a) ; the peak was well defined with good separation from any endogenous matrix peaks (Fig. 1b) . The stability of the OTZ in SAH was evaluated by running three freeze/thaw cycles which revealed no change in the OTZ concentration in SAH.
OTZ-loaded chitosan nanoparticles
Size and ζ-potential of the formulated chitosan nanoparticles are amongst the most important parameters that control the bioactivity and biocompatibility of the prepared particles [4] ; smaller particles are likely to have a higher permeation than larger ones, and positively charged particles are likely to have longer ocular retention time due the presence of the negatively charged mucin layer [2] . The particle size and ζ-potential of the prepared chitosan nanoparticles were measured and found to be 153±3 nm and 26±0.5 mV, respectively (Fig. 2a, b) . Our particle sizes were smaller compared to those of Calvo et al. [4] , and the surface charge of the prepared particles was positive due the presence of the protonated amine groups on the chitosan backbone. The polydispersity index was 0.08 which indicates monodisperse systems.
The morphology of chitosan nanoparticles was elucidated using SEM (Fig. 2c) and AFM (Fig. 2d) . The particles appeared to be spherical, uniform in shape, with limited aggregation. AFM topography images were obtained, in air, from four replicates, each prepared from aqueous solutions. The particle diameters determined using AFM were found to be in agreement with diameters obtained from particle size analyses and SEM images and not influenced by possible tipbroadening artefacts [9] .
In vitro release of OTZ The release profile of OTZ from chitosan nanoparticles indicated an initial burst release of OTZ over the first 6 h which likely is caused by the rapid desorption of the OTZ molecules that are adsorbed onto the surface of the chitosan nanoparticles. This was followed by a sustained release phase where the rate of OTZ release declined notably most likely because of the slow diffusion of OTZ from the core of the chitosan nanoparticles [4] . The percentage of OTZ released over the period of the experiment was 14.7 % which is in agreement with previous results [4] .
These findings suggest that a significant amount of OTZ has been retained in the nanoparticle system most likely because of the strong electrostatic interaction between the positively charged amine groups of the chitosan amine groups and the negatively charged OTZ. Nevertheless, the amount of released OTZ is still within the therapeutic window and, as such, would be suitable for the intended purpose [10] . The OTZ permeation through excised bovine cornea profile is linear, indicating that the corneal epithelium controls the permeation of OTZ. The lag time and the corneal flux of OTZ were calculated and found to be 0.2 h and 3.05 μg/cm 2 H, respectively, while the P app was found to be 3.2×10 −7 cm s −1
.
Conclusion
A new method for separation and quantification of OTZ in SAH has been developed and validated according to FDA guidelines. This method highlights the advantage of employing an HILIC column to overcome the hydrophilicity challenge characteristic of OTZ. The method was found to be accurate, precise, selective and highly sensitive with a LLOD of 100 ng/mL and a LLOQ of 200 ng/mL. OTZ-loaded chitosan nanoparticles were formulated by ionic gelation and investigated for particle size and morphology. The amount of OTZ released and permeated across excised bovine eye cornea was quantified using the developed method.
